Acarbose Reduces Diabetes Risk in Coronary Heart Disease
Incidence of new-onset diabetes was 18% lower in the acarbose group than in the placebo group during a median of 4.4 years of follow-up.
Investigators sought to determine whether the use of dipeptidyl peptidase-4 inhibitors is associated with the incidence of rheumatoid arthritis.
Greater adherence to an overall healthy lifestyle is associated with a substantially lower risk for cardiovascular disease.
Antidiabetic agents for the treatment of diabetes including maintenance and max doses.